XML 15 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Operating activities        
Net income (loss) $ 191,900 $ (349,447)
Adjustments for:      
Depreciation, depletion, and amortization 85,068 91,852
Reclamation and remediation costs 81,305 280,146
Payments for reclamation and remediation liabilities (17,325) (126,848)
Deferred income taxes (30,365) (31,676)
Stock-based compensation 40,658 562
Change in fair value of marketable securities (6,742) (6,749)
Non-cash fair value adjustment on acquired inventories 0 2,830
Loss (gain) on sale and disposal of assets, net 1,533 (5,133)
Impairment charges of long-lived and other assets 0 114,599
Change in fair value of deferred consideration 6,542 (2,208)
Other taxes 2,277 4,865
Loss on foreign exchange 26,405 10,448
Non-cash care and maintenance 45,860 35,157
Other operating activities 5,904 4,374
Net change in operating assets and liabilities   (133,218) (77,621)
Net cash provided by (used in) operating activities 299,802 (54,849)
Investing activities    
Additions to mineral properties, plant and equipment (164,519) (104,961)
Acquisitions, net (105,960) 0
Purchases of marketable securities (84,443) (22,262)
Net proceeds from sale of marketable securities 67,911 19,268
Proceeds from sale of mineral properties, plant and equipment 0 4,853
Other investing activities 656 (454)
Net cash used in investing activities (286,355) (103,556)
Financing activities     
Repayment of debt, principal 0 (920)
Proceeds from the issuance of debt, related party 24,300 18,375
Repurchase of common shares 0 (9,825)
Principal payments on finance leases (3,573) (3,020)
Net cash provided by financing activities 20,727 4,610
Effect of foreign exchange rate changes on cash and cash equivalents (12,724) (4,358)
Net increase (decrease) in cash, cash equivalents, and restricted cash 21,450 (158,153)
Cash, cash equivalents, and restricted cash beginning of period 387,882 492,494
Cash, cash equivalents, and restricted cash end of period $ 409,332 $ 334,341